Summary

Japan Biotechnology Market Summary, Competitive Analysis and Forecast, 2017-2026

Summary

Biotechnology in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
- The Japanese biotechnology market had total revenues of $65.1 billion in 2021, representing a compound annual growth rate (CAGR) of 12.9% between 2016 and 2021.
- The environment & industrial processing segment generated the most revenue in 2021, with total revenues of $25.3 billion, equivalent to 38.9% of the market's overall value.
- The Japanese market is the second largest in the Asia-Pacific region, accounting for 26.1% of its total value in 2021, ahead of China’s 15.6%.

Scope

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Japan
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Japan
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Japan biotechnology market with five year forecasts

Reasons to Buy

- What was the size of the Japan biotechnology market by value in 2021?
- What will be the size of the Japan biotechnology market in 2026?
- What factors are affecting the strength of competition in the Japan biotechnology market?
- How has the market performed over the last five years?
- What are the main segments that make up Japan's biotechnology market?

ページTOPに戻る

Table of Contents

Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What has been the rationale behind recent M&A activity?
7.4. Are there any notable threats to leading players in this market?
8 Company Profiles
8.1. Takeda Pharmaceutical Company Limited
8.2. Astellas Pharma Inc.
8.3. Daiichi Sankyo Co Ltd
8.4. Mitsubishi Tanabe Pharma Corporation
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine